Who Paid My Doc
Otiprio
Drug Otolaryngology
NDC 69251-201-01
General payments
$110,893
Research payments
$1,138
Through program year 2022, $110,893 in general payments and $1,138 in research payments were reported against Otiprio (Otolaryngology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $36,736 | 1,293 |
| 2021 | General | $59,687 | 1,913 |
| 2020 | General | $10,938 | 637 |
| 2019 | General | $3,532 | 4 |
| 2019 | Research | $1,138 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 38 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
3,847 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.